NSPR News and Press, InspireMD Inc. From 04/14/21

InspireMD (NSPR) announces a 1-for-15 reverse split of its common stock, effective as of Apr. 26, 2021.That means the company's outstanding shares will be reduced from approximately 118M to ~7.9M. The stock will trade on split adjusted basis from the market open on Apr. 27, 2021.Press Re...

TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced a 1-for-15 rev...

Are These Hot Penny Stocks To Buy Right Now? There is a lot of excitement involving penny stocks this year. Much of this has stemmed from the pandemic, sure, but there are other things to factor in more recently. In recent weeks, one of the more active market sectors has been biotech, a...

TEL AVIV, Israel, March 22, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of the stroke caused by carotid artery disease, today issues a message to stockholders from InspireMD CEO, Marvin Sl...

Do These Biotech Penny Stocks Have Market Potential Right Now? Recently biotech penny stocks have been performing well in the market. The ongoing pandemic brought a lot of new attention to these stocks. Plenty of corporations started working on creating COVID-related vaccines or treatme...

Will These 4 Penny Stocks Keep Up Their Bullishness This Week? Penny stocks have been on a bullish journey this month. While there have been days where the market is down, investors are showing a lot of upbeat sentiment toward the future. In March, the path of Covid has changed dramatic...

InspireMD, Inc. (NSPR) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants Scott Gordon - President, Core IR, Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer Conference Call Participants Benjamin Haynor - Alliance...

InspireMD (NSPR): Q4 GAAP EPS of -$0.10 misses by $0.03.Revenue of $0.16M (-84.2% Y/Y) misses by $0.94M.Press Release For further details see: InspireMD EPS misses by $0.03, misses on revenue

TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results f...

TEL AVIV, Israel, March 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) (“InspireMD” or the “Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), tod...